IRIDEX Corporation
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and Oc… Read more
IRIDEX Corporation (IRIX) - Total Assets
Latest total assets as of September 2025: $28.35 Million USD
Based on the latest financial reports, IRIDEX Corporation (IRIX) holds total assets worth $28.35 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
IRIDEX Corporation - Total Assets Trend (1995–2024)
This chart illustrates how IRIDEX Corporation’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
IRIDEX Corporation - Asset Composition Analysis
Current Asset Composition (December 2024)
IRIDEX Corporation's total assets of $28.35 Million consist of 80.9% current assets and 19.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.2% |
| Accounts Receivable | $8.39 Million | 28.8% |
| Inventory | $10.82 Million | 37.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $1.31 Million | 4.5% |
| Goodwill | $965.00K | 3.3% |
Asset Composition Trend (1995–2024)
This chart illustrates how IRIDEX Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IRIDEX Corporation's current assets represent 80.9% of total assets in 2024, a decrease from 93.8% in 1995.
- Cash Position: Cash and equivalents constituted 8.2% of total assets in 2024, down from 18.8% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 7.0% of total assets, an increase from 0.0% in 1995.
- Asset Diversification: The largest asset category is inventory at 37.1% of total assets.
IRIDEX Corporation Competitors by Total Assets
Key competitors of IRIDEX Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
IRIDEX Corporation - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - IRIDEX Corporation generates 1.67x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - IRIDEX Corporation is currently not profitable relative to its asset base.
IRIDEX Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.94 | 1.54 | 2.92 |
| Quick Ratio | 1.35 | 0.85 | 2.26 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $11.67 Million | $ 8.48 Million | $ 16.68 Million |
IRIDEX Corporation - Advanced Valuation Insights
This section examines the relationship between IRIDEX Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 331.20 |
| Latest Market Cap to Assets Ratio | 0.51 |
| Asset Growth Rate (YoY) | -15.4% |
| Total Assets | $29.14 Million |
| Market Capitalization | $14.96 Million USD |
Valuation Analysis
Below Book Valuation: The market values IRIDEX Corporation's assets below their book value (0.51 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: IRIDEX Corporation's assets decreased by 15.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for IRIDEX Corporation (1995–2024)
The table below shows the annual total assets of IRIDEX Corporation from 1995 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $29.14 Million | -15.39% |
| 2023-12-31 | $34.44 Million | -18.57% |
| 2022-12-31 | $42.29 Million | -13.14% |
| 2021-12-31 | $48.69 Million | +74.07% |
| 2020-12-31 | $27.97 Million | -19.66% |
| 2019-12-31 | $34.81 Million | -16.46% |
| 2018-12-31 | $41.67 Million | +0.06% |
| 2017-12-31 | $41.65 Million | -13.50% |
| 2016-12-31 | $48.14 Million | +15.11% |
| 2015-12-31 | $41.82 Million | +0.01% |
| 2014-12-31 | $41.82 Million | +24.17% |
| 2013-12-31 | $33.68 Million | +16.48% |
| 2012-12-31 | $28.91 Million | -10.07% |
| 2011-12-31 | $32.15 Million | +10.02% |
| 2010-12-31 | $29.22 Million | +3.28% |
| 2009-12-31 | $28.29 Million | +0.23% |
| 2008-12-31 | $28.23 Million | -39.50% |
| 2007-12-31 | $46.65 Million | +16.12% |
| 2006-12-31 | $40.18 Million | -2.26% |
| 2005-12-31 | $41.10 Million | +5.14% |
| 2004-12-31 | $39.09 Million | +9.08% |
| 2003-12-31 | $35.84 Million | +4.57% |
| 2002-12-31 | $34.27 Million | +1.43% |
| 2001-12-31 | $33.79 Million | -3.53% |
| 2000-12-31 | $35.02 Million | +7.22% |
| 1999-12-31 | $32.66 Million | +15.02% |
| 1998-12-31 | $28.40 Million | +6.37% |
| 1997-12-31 | $26.70 Million | +12.66% |
| 1996-12-31 | $23.70 Million | +270.31% |
| 1995-12-31 | $6.40 Million | -- |